Medikaloka Hermina Tbk PT
IDX:HEAL

Watchlist Manager
Medikaloka Hermina Tbk PT Logo
Medikaloka Hermina Tbk PT
IDX:HEAL
Watchlist
Price: 1 440 IDR Market Closed
Market Cap: 22.1T IDR

Intrinsic Value

The intrinsic value of one HEAL stock under the Base Case scenario is hidden IDR. Compared to the current market price of 1 440 IDR, Medikaloka Hermina Tbk PT is hidden .

The Intrinsic Value is calculated as the average of DCF and Relative values:

HEAL Intrinsic Value
HIDDEN
Show
Base Case Scenario

Valuation History
Medikaloka Hermina Tbk PT

Intrinsic Value History
Dive into the past to invest in the future

HEAL looks overvalued. Yet it might still be cheap by its own standards. Some stocks live permanently above intrinsic value; Historical Valuation reveals whether HEAL usually does or if today's premium is unusual.

Learn how current stock valuations stack up against historical averages to gauge true investment potential.

Show Historical Valuation
What is Valuation History?
Ask AI Assistant
What other research platforms think about HEAL?

Let our AI compare Alpha Spread’s intrinsic value with external valuations from Simply Wall St, GuruFocus, ValueInvesting.io, Seeking Alpha, and others.

Discover External Valuations
Why is HEAL valued this way?

Let our AI break down the key assumptions behind the intrinsic value calculation for Medikaloka Hermina Tbk PT.

Explain Valuation
Compare HEAL to

Fundamental Analysis

Company Overview
Loading...
Business Segments
Loading...
Economic Moat
Loading...
Management
Loading...
Contacts
Loading...
How do you feel about HEAL?
Bearish
Neutral
Bullish
Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Medikaloka Hermina Tbk PT

Current Assets 2.5T
Cash & Short-Term Investments 956.8B
Receivables 1.4T
Other Current Assets 148.8B
Non-Current Assets 9.3T
Long-Term Investments 21.8B
PP&E 8.9T
Other Non-Current Assets 363.9B
Current Liabilities 1.5T
Accounts Payable 417.1B
Accrued Liabilities 179.8B
Short-Term Debt 33.9B
Other Current Liabilities 893.9B
Non-Current Liabilities 4.7T
Long-Term Debt 3.1T
Other Non-Current Liabilities 1.6T
Efficiency

Free Cash Flow Analysis
Medikaloka Hermina Tbk PT

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
Medikaloka Hermina Tbk PT

Revenue
7T IDR
Cost of Revenue
-4.6T IDR
Gross Profit
2.3T IDR
Operating Expenses
-1.4T IDR
Operating Income
945.5B IDR
Other Expenses
-521.8B IDR
Net Income
423.8B IDR
Fundamental Scores

HEAL Profitability Score
Profitability Due Diligence

Medikaloka Hermina Tbk PT's profitability score is hidden . The higher the profitability score, the more profitable the company is.

Healthy Gross Margin
Sustainable 3Y Average Gross Margin
Healthy Operating Margin
Sustainable 3Y Average Operating Margin
hidden
Profitability
Score

Medikaloka Hermina Tbk PT's profitability score is hidden . The higher the profitability score, the more profitable the company is.

HEAL Solvency Score
Solvency Due Diligence

Medikaloka Hermina Tbk PT's solvency score is hidden . The higher the solvency score, the more solvent the company is.

High Altman Z-Score
Low D/E
Long-Term Solvency
Short-Term Solvency
hidden
Solvency
Score

Medikaloka Hermina Tbk PT's solvency score is hidden . The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

HEAL Price Targets Summary
Medikaloka Hermina Tbk PT

Wall Street analysts forecast HEAL stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for HEAL is 1 746.47 IDR with a low forecast of 1 343.3 IDR and a high forecast of 2 047.5 IDR.

Lowest
Price Target
1 343.3 IDR
7% Downside
Average
Price Target
1 746.47 IDR
21% Upside
Highest
Price Target
2 047.5 IDR
42% Upside
View Analyst Estimates
View Analyst Estimates

Dividends

Dividend Yield
Lowest
Average
Highest
Dividend Per Share
Growth 3Y
Growth 5Y
Growth 10Y
Dividend Safety Score
Very
Unsafe
Unsafe
Safe
Very
Safe
0
25
50
75
100
Shareholder Yield

Current shareholder yield for HEAL is hidden .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
HIDDEN
Show
Dividend Yield
Lowest
Average
Highest
Buyback Yield
HIDDEN
Debt Paydown Yield
HIDDEN

Competitive Landscape

Company Market Cap Intrinsic Valuation Profitability Solvency Price Change
1Y 3Y 5Y
What is the Intrinsic Value of one HEAL stock?

The intrinsic value of one HEAL stock under the Base Case scenario is hidden IDR.

Is HEAL stock undervalued or overvalued?

Compared to the current market price of 1 440 IDR, Medikaloka Hermina Tbk PT is hidden .

Back to Top